Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

You may be eligible if

• Criteria:
• Platelet count at least 100,000/mm\^3
• No leukemia
• No active CNS involvement with tumor
• ECOG 0-2
• Life expectancy: at least 3 months
• Absolute neutrophil count at least 2,000/mm\^3
• No New York Heart Association class III or IV heart failure
• No history of myocardial infarction within the past year
• Bilirubin =\< upper limit of normal (ULN)
• AST no greater than 2 times ULN (no greater than 98 U/L)
• No uncontrolled dysrhythmias
• No poorly controlled angina
• No serious ventricular arrhythmia (i.e., ventricular tachycardia (VT) or ventricular fibrillation (VF) \>= 3 beats in a row)
• QTc interval =\< 450 msec for men or =\< 470 msec for women
• LVEF \>= 40% by MUGA
• Not pregnant or nursing
• Negative pregnancy test
• Fertile patients must use effective contraception
• HIV negative
• No other serious medical condition that would preclude study participation
• No serious hypersensitivity to egg products
• No concurrent anticancer immunotherapy
• At least 4 weeks since prior chemotherapy and recovered
• No other concurrent anticancer chemotherapy (e.g., cyclophosphamide, doxorubicin, vincristine, and prednisone \[CHOP\] or mechlorethamine, vincristine, procarbazine, and prednisone \[MOPP\])
• No concurrent anticancer hormonal therapy
• Concurrent glucocorticoids as antiemetics for nonmalignant disease allowed
• At least 4 weeks since prior radiotherapy and recovered
• No concurrent radiotherapy
• No concurrent major surgery
• No concurrent anticancer glucocorticoids
• Creatinine =\< ULN or Creatinine clearance at least 60 mL/min
• No concurrent medications that cause QTc prolongation
• Histologically confirmed advanced solid tumor for which no curative therapy exists
• Non-Hodgkin's lymphoma allowed
• No concurrent drugs that interfere with hepatic CYP3A4 metabolism (e.g., grapefruit juice, ketoconazole, fluconazole, itraconazole, cyclosporine, erythromycin, clarithromycin, cimetidine, terfenadine, astemizole, indinavir, or nelfinavir mesylate)